Skip to main content

Emmaus Life Sciences, Inc.

EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000822370

In the last 90 days, Emmaus Life Sciences, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Superinvestors holding EMMA, Q2 2026

See all superinvestors

No superinvestor reported holding EMMA in Q2 2026.